FDA Brief

Company record

Sourav K. Mishra, M.D. / All India Institute of Medical Sciences

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Sourav K. Mishra, M.D. / All India Institute of Medical Sciences.

Warning letters

  1. Sourav K. Mishra, M.D. / All India Institute of Medical Sciences

    FDA warned clinical investigator Dr. Sourav K. Mishra at AIIMS Bhubaneswar over a doxorubicin liposome bioequivalence study that broke protocol and consent rules.

    High risk